Cancer of the ovary

[41] 2-X

[42] Dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients [J]. GYNECOLOGIC ONCOLOGY, 2001, 83 (02) : 394 - 399

[43] INFLUENCE OF SECONDARY CYTOREDUCTION AT THE TIME OF 2ND-LOOK LAPAROTOMY ON THE SURVIVAL OF PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA [J]. GYNECOLOGIC ONCOLOGY, 1989, 34 (03) : 365 - 371

[44] International Collaborative Ovarian Neoplasm Group, 2003, LANCET, V361, P706

[45] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) : 1609 - 1615

[46] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 [J]. SCIENCE, 2003, 302 (5645) : 643 - 646

[47] In situ detection of parathyroid hormone-related protein in ovarian clear cell carcinoma [J]. HUMAN PATHOLOGY, 1997, 28 (03) : 379 - 382

[48] LAVIN PT, 1987, OBSTET GYNECOL, V69, P223

[49] Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4222 - 4227

[50] Clinical proteomics - Personalized molecular medicine [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18): : 2211 - 2214

[41] 2-X

[42] Dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients [J]. GYNECOLOGIC ONCOLOGY, 2001, 83 (02) : 394 - 399

[43] INFLUENCE OF SECONDARY CYTOREDUCTION AT THE TIME OF 2ND-LOOK LAPAROTOMY ON THE SURVIVAL OF PATIENTS WITH EPITHELIAL OVARIAN-CARCINOMA [J]. GYNECOLOGIC ONCOLOGY, 1989, 34 (03) : 365 - 371

[44] International Collaborative Ovarian Neoplasm Group, 2003, LANCET, V361, P706

[45] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) : 1609 - 1615

[46] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 [J]. SCIENCE, 2003, 302 (5645) : 643 - 646

[47] In situ detection of parathyroid hormone-related protein in ovarian clear cell carcinoma [J]. HUMAN PATHOLOGY, 1997, 28 (03) : 379 - 382

[48] LAVIN PT, 1987, OBSTET GYNECOL, V69, P223

[49] Fallopian tube and primary peritoneal carcinomas associated with BRCA mutations [J]. JOURNAL OF CLINICAL ONCOLOGY, 2003, 21 (22) : 4222 - 4227

[50] Clinical proteomics - Personalized molecular medicine [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (18): : 2211 - 2214